USE OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR (EGFR) IN GEFITINIB RESISTANT PATIENTS
摘要
This invention discloses method of treating or inhibiting cancer in a human having at least one of an Exon 19 del E746-A750 and/or an Exon 21 point mutation comprising administering to said human gefitinib and/or iressa alone or in combination with other cytotoxic agents or chemotherapeutic agents and an effective amount of EGFR kinase inhibitor.
申请公布号
WO2006113151(A3)
申请公布日期
2007.01.11
申请号
WO2006US12877
申请日期
2006.04.07
申请人
WYETH;ZACHARCHUK, CHARLES M;QUINN, SUSAN E.;MARTINS, PATRICIA;GREENBERGER, LEE;LUNDBERG, ANTE (BILL)
发明人
ZACHARCHUK, CHARLES M;QUINN, SUSAN E.;MARTINS, PATRICIA;GREENBERGER, LEE;LUNDBERG, ANTE (BILL)